TARDBP and amyotrophic lateral sclerosis: In summary, the results herein presented show neuroprotective effects of Tideglusib both in vitro and in vivo as it restores TDP-43 homeostasis by reducing the aberrant phosphorylation of TDP-43, a consistent feature observed in the cytoplasmic aggregates in affected tissues of about 97% of ALS patients.